Showing results (141-150 of 196) with videos related to
Sort By:
Pageof 20
Liver Cancer|August 21, 2023
Risk Factors for Early Onset of Proteinuria in Patients Receiving Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular CarcinomaYuwa Ando, Tomokazu Kawaoka, Masanari Kosaka, et al.Journal of Gastroenterology and Hepatology|January 3, 2020
Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy casesKana Daijo, Takashi Nakahara, Yuki Inagaki, et al.BMC Cancer|June 6, 2018
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trialMasahiro Hatooka, Tomokazu Kawaoka, Hiroshi Aikata, et al.Antimicrobial Agents and Chemotherapy|March 30, 2011
Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosineAngela M Lam, Christine Espiritu, Eisuke Murakami, et al.Cancers|August 27, 2021
Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World PracticeYuwa Ando, Tomokazu Kawaoka, Masanari Kosaka, et al.Hepatology Communications|March 13, 2019
Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver CirrhosisAkira Hiramatsu, Hiroshi Aikata, Shinsuke Uchikawa, et al.Clinical and Translational Gastroenterology|July 18, 2020
Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular CarcinomaMasami Yamauchi, Atsushi Ono, Akira Ishikawa, et al.Medicine|June 30, 2021
Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patientsEisuke Murakami, Takashi Nakahara, Akira Hiramatsu, et al.Antimicrobial Agents and Chemotherapy|April 25, 2012
Metabolic activation of the anti-hepatitis C virus nucleotide prodrug PSI-352938Congrong Niu, Tatiana Tolstykh, Haiying Bao, et al.Therapeutic Advances in Medical Oncology|June 18, 2020
Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinibAtsushi Ono, Hiroshi Aikata, Masami Yamauchi, et al.Pageof 20